发明名称 TERT-BUTYL N-[2-{4-[6-AMINO-5-(2,4-DIFLUOROBENZOYL)-2-OXOPYRIDIN-1(2H)-YL]-3,5- DIFLUOROPHENYL}ETHYL]-L-ALANINATE OR A SALT, HYDRATE OR SOLVATE THEREOF
摘要 The present invention provides a compound which is: tert-butyl N-[2-{4-[6-amino-5-(2,4-difluorobenzoyl)-2-oxopyridin-1(2H)-yl]-3,5-difluorophenyl}ethyl)-L-alaninate or a salt, hydrate or solvate thereof. The present invention also provides a pharmaceutical composition comprising the compound together with one or more pharmaceutically acceptable carriers and/or excipients. The compound and composition are useful for inhibiting the activity of a p38 MAP kinase enzyme. As such they may be used in the treatment of a autoimmune or inflammatory disease, or a cell proliferative disease. In addition, the invention provides an acid produced by hydrolysis of the ester group of the compound of the invention. The acid is N-[2-{4-[6-amino-5-(2,4-difluorobenzoyl)-2-oxopyridin-1(2H)-yl]-3,5-difluorophenyl}ethyl)-L-alanine.
申请公布号 SG11201502515V(A) 申请公布日期 2015.05.28
申请号 SG11201502515V 申请日期 2013.10.15
申请人 CHROMA THERAPEUTICS LTD 发明人 PINTAT, STÉPHANE;DAVIES, STEPHEN, JOHN;MOFFAT, DAVID, FESTUS, CHARLES
分类号 C07D213/73;A61K31/4412;A61P29/00;A61P35/00 主分类号 C07D213/73
代理机构 代理人
主权项
地址